These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

479 related items for PubMed ID: 17889463

  • 1. A multicenter, prospective, randomized, double-blind, placebo-controlled study to investigate the efficacy of a continuous-combined hormone therapy preparation containing 1mg estradiol valerate/2mg dienogest on hot flushes in postmenopausal women.
    Endrikat J, Graeser T, Mellinger U, Ertan K, Holz C.
    Maturitas; 2007 Oct 20; 58(2):201-7. PubMed ID: 17889463
    [Abstract] [Full Text] [Related]

  • 2. A one-year randomized double-blind, multicentre study to evaluate the effects of an oestrogen-reduced, continuous combined hormone replacement therapy preparation containing 1 mg oestradiol valerate and 2 mg dienogest on metabolism in postmenopausal women.
    Endrikat J, Lange E, Kunz M, Schmidt W, Graeser T.
    Eur J Contracept Reprod Health Care; 2007 Sep 20; 12(3):229-39. PubMed ID: 17763261
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and tolerability of estradiol 1 mg and drospirenone 2 mg in postmenopausal Korean women: a double-blind, randomized, placebo-controlled, multicenter study.
    Lee BS, Kang BM, Yoon BK, Choi H, Park HM, Kim JG.
    Maturitas; 2007 Aug 20; 57(4):361-9. PubMed ID: 17467203
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and tolerability of continuous combined hormone replacement therapy in early postmenopausal women.
    Mattsson LA, Skouby S, Rees M, Heikkinen J, Kudela M, Stadnicki-Kolendo A, Mattila L, Salminen K, Vuorela A, Mustonen M, Indivina 321 Study Group.
    Menopause Int; 2007 Sep 20; 13(3):124-31. PubMed ID: 17785038
    [Abstract] [Full Text] [Related]

  • 5. Lowest effective transdermal 17beta-estradiol dose for relief of hot flushes in postmenopausal women: a randomized controlled trial.
    Bachmann GA, Schaefers M, Uddin A, Utian WH.
    Obstet Gynecol; 2007 Oct 20; 110(4):771-9. PubMed ID: 17906008
    [Abstract] [Full Text] [Related]

  • 6. Estradiol in micellar nanoparticles: the efficacy and safety of a novel transdermal drug-delivery technology in the management of moderate to severe vasomotor symptoms.
    Simon JA, ESTRASORB Study Group.
    Menopause; 2006 Oct 20; 13(2):222-31. PubMed ID: 16645536
    [Abstract] [Full Text] [Related]

  • 7. [Evaluation the efficacy and safety of estradiol and drospirenone tablets in the treatment of menopausal symptoms among postmenopausal Chinese healthy women:a randomized, multi-center, double-blind, placebo-controlled clinical study].
    Zhou YZ, Sun LZ, Lin JF, Yang X, Zhang LJ, Qiao J, Wang ZH, Xu YX, Xiong ZA, Lin SQ.
    Zhonghua Fu Chan Ke Za Zhi; 2011 May 20; 46(5):345-9. PubMed ID: 21733370
    [Abstract] [Full Text] [Related]

  • 8. Clinical efficacy and safety of combined estradiol valerate and dienogest: a new no-bleed treatment.
    von Schoultz B.
    Climacteric; 2003 Aug 20; 6 Suppl 2():24-32. PubMed ID: 14669841
    [Abstract] [Full Text] [Related]

  • 9. A 1-year comparison of the efficacy and clinical tolerance in postmenopausal women of two hormone replacement therapies containing estradiol in combination with either norgestrel or trimegestone.
    Meuwissen JH, Beijers-De Bie L, Vihtamaki T, Tuimala R, Siseles N, Magaril C, The HS, Houben PW, Murga M, Spielmann D, De Villiers TJ.
    Gynecol Endocrinol; 2001 Oct 20; 15(5):349-58. PubMed ID: 11727357
    [Abstract] [Full Text] [Related]

  • 10. Vasomotor hot flushes and 24-hour ambulatory blood pressure in normotensive women: A placebo-controlled trial on post-menopausal hormone therapy.
    Tuomikoski P, Haapalahti P, Sarna S, Ylikorkala O, Mikkola TS.
    Ann Med; 2010 Jul 20; 42(5):334-43. PubMed ID: 20429800
    [Abstract] [Full Text] [Related]

  • 11. Percutaneous 17beta-estradiol gel for the treatment of vasomotor symptoms in postmenopausal women.
    Archer DF, EstroGel Study Group.
    Menopause; 2003 Jul 20; 10(6):516-21. PubMed ID: 14627859
    [Abstract] [Full Text] [Related]

  • 12. Predictors of hot flushes in postmenopausal women who receive raloxifene therapy.
    Aldrighi JM, Quail DC, Levy-Frebault J, Aguas F, Kosian K, Garrido L, Bosio-Le Goux B, Saráchaga M, Graebe A, Niño AJ, Nickelsen T.
    Am J Obstet Gynecol; 2004 Dec 20; 191(6):1979-88. PubMed ID: 15592280
    [Abstract] [Full Text] [Related]

  • 13. Estradiol 1 mg and drospirenone 2 mg as hormone replacement therapy in postmenopausal Chinese women.
    Lin SQ, Sun LZ, Lin JF, Yang X, Zhang LJ, Qiao J, Wang ZH, Xu YX, Xiong ZA, Zhou YZ, Wang ML, Zhu J, Chen SR, Su H, Yang CS, Wang SH, Zhang YZ, Dong XJ.
    Climacteric; 2011 Aug 20; 14(4):472-81. PubMed ID: 21469973
    [Abstract] [Full Text] [Related]

  • 14. Transition from estrogen-progestin to raloxifene in postmenopausal women: effect on vasomotor symptoms.
    Gordon S, Walsh BW, Ciaccia AV, Siddhanti S, Rosen AS, Plouffe L.
    Obstet Gynecol; 2004 Feb 20; 103(2):267-73. PubMed ID: 14754694
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of a soy isoflavone extract in postmenopausal women: a randomized, double-blind, and placebo-controlled study.
    Nahas EA, Nahas-Neto J, Orsatti FL, Carvalho EP, Oliveira ML, Dias R.
    Maturitas; 2007 Nov 20; 58(3):249-58. PubMed ID: 17913408
    [Abstract] [Full Text] [Related]

  • 16. Estrogen therapy selectively enhances prefrontal cognitive processes: a randomized, double-blind, placebo-controlled study with functional magnetic resonance imaging in perimenopausal and recently postmenopausal women.
    Joffe H, Hall JE, Gruber S, Sarmiento IA, Cohen LS, Yurgelun-Todd D, Martin KA.
    Menopause; 2006 Nov 20; 13(3):411-22. PubMed ID: 16735938
    [Abstract] [Full Text] [Related]

  • 17. Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study.
    D'Anna R, Cannata ML, Atteritano M, Cancellieri F, Corrado F, Baviera G, Triolo O, Antico F, Gaudio A, Frisina N, Bitto A, Polito F, Minutoli L, Altavilla D, Marini H, Squadrito F.
    Menopause; 2007 Nov 20; 14(4):648-55. PubMed ID: 17251874
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of a new, oral estradiol acetate formulation for relief of menopause symptoms.
    Speroff L, Haney AF, Gilbert RD, Ellman H, Estradiol Acetate Investigator Group.
    Menopause; 2006 Nov 20; 13(3):442-50. PubMed ID: 16735941
    [Abstract] [Full Text] [Related]

  • 19. Micro-dose transdermal estradiol for relief of hot flushes in postmenopausal Asian women: a randomized controlled trial.
    Haines C, Yu SL, Hiemeyer F, Schaefers M.
    Climacteric; 2009 Oct 20; 12(5):419-26. PubMed ID: 19479489
    [Abstract] [Full Text] [Related]

  • 20. Sleep, vigilance and cognition in postmenopausal women: placebo-controlled studies with 2 mg estradiol valerate, with and without 3 mg dienogest.
    Saletu B.
    Climacteric; 2003 Aug 20; 6 Suppl 2():37-45. PubMed ID: 14669843
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.